title: Indispensability of UGT1A1*6 genotyping in Japanese cancer patients treated with irinotecan.
authors.forename: Masashi
authors.initials: M
authors.lastname: Takano
authors.forename: Masafumi
authors.initials: M
authors.lastname: Kato
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Yoshikawa
authors.forename: Tomoko
authors.initials: T
authors.lastname: Goto
authors.forename: Kenichi
authors.initials: K
authors.lastname: Furuya
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Kikuchi
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000378:metabolism; D044466:Asian People / Q000235:genetics*; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism; D020022:Genetic Predisposition to Disease; D005838:Genotype; D014453:Glucuronosyltransferase / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D000077146:Irinotecan; D007564:Japan; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000208:ethnology / Q000235:genetics; D009503:Neutropenia / Q000139:chemically induced* / Q000235:genetics; D010641:Phenotype; D011110:Polymorphism, Genetic; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D000099148:UGT1A1 Enzyme
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D002166:Camptothecin; D014453:Glucuronosyltransferase; D000077146:Irinotecan; D000099148:UGT1A1 Enzyme